Back to Search
Start Over
Prophylactic tocilizumab reduces the incidence of cytokine release syndrome in relapsed/refractory myeloma patients treated with teclistamab: Implications for outpatient step‐up dosing.
- Source :
- HemaSphere; Jul2024, Vol. 8 Issue 7, p1-4, 4p
- Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 25729241
- Volume :
- 8
- Issue :
- 7
- Database :
- Complementary Index
- Journal :
- HemaSphere
- Publication Type :
- Academic Journal
- Accession number :
- 178642326
- Full Text :
- https://doi.org/10.1002/hem3.132